Professor Gerry Hanna:

On that point of clinical academics or clinicians coming home to work here, we are very lucky. We have some of the best in the world who have just returned, particularly in the past five years. We are at a really unique point where with not a lot of extra input, we could really get to the next level. That investment, particularly in clinical trials, and that connected network of service, alignment of clinical pathways, a joint cancer strategy - you can see all the bits. If we could simply bring those together, we would become the Royal Marsden or the Memorial Sloan Kettering of Europe and that is where we want to be. We know we can do it around our comprehensive cancer centres so why not do it for all the units across Ireland through a network approach?